NCT06206694View on ClinicalTrials.gov

Serum YKL-40 Levels is Associated With Nutritional and Oxidative Status of Hemodialysis Patients

CompletedOBSERVATIONAL
Enrollment

226

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
MalnutritionOxidative Stress
Trial Locations (1)

Unknown

Tungs' Taichung MetroHarbour Hospital, Taichung

All Listed Sponsors
lead

Tungs' Taichung Metroharbour Hospital

OTHER

NCT06206694 - Serum YKL-40 Levels is Associated With Nutritional and Oxidative Status of Hemodialysis Patients | Biotech Hunter | Biotech Hunter